239 related articles for article (PubMed ID: 9633698)
1. Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease.
Ibáñez V; Pietrini P; Alexander GE; Furey ML; Teichberg D; Rajapakse JC; Rapoport SI; Schapiro MB; Horwitz B
Neurology; 1998 Jun; 50(6):1585-93. PubMed ID: 9633698
[TBL] [Abstract][Full Text] [Related]
2. Positron emission tomography metabolic data corrected for cortical atrophy using magnetic resonance imaging.
Labbé C; Froment JC; Kennedy A; Ashburner J; Cinotti L
Alzheimer Dis Assoc Disord; 1996; 10(3):141-70. PubMed ID: 8876777
[TBL] [Abstract][Full Text] [Related]
3. The effect of brain atrophy on cerebral hypometabolism in the visual variant of Alzheimer disease.
Bokde AL; Pietrini P; Ibáñez V; Furey ML; Alexander GE; Graff-Radford NR; Rapoport SI; Schapiro MB; Horwitz B
Arch Neurol; 2001 Mar; 58(3):480-6. PubMed ID: 11255453
[TBL] [Abstract][Full Text] [Related]
4. Regional hypometabolism in Alzheimer's disease as measured by positron emission tomography after correction for effects of partial volume averaging.
Meltzer CC; Zubieta JK; Brandt J; Tune LE; Mayberg HS; Frost JJ
Neurology; 1996 Aug; 47(2):454-61. PubMed ID: 8757020
[TBL] [Abstract][Full Text] [Related]
5. Quantitative analysis of PET and MRI data in normal aging and Alzheimer's disease: atrophy weighted total brain metabolism and absolute whole brain metabolism as reliable discriminators.
Alavi A; Newberg AB; Souder E; Berlin JA
J Nucl Med; 1993 Oct; 34(10):1681-7. PubMed ID: 8410281
[TBL] [Abstract][Full Text] [Related]
6. A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment and early Alzheimer's disease.
Croteau E; Castellano CA; Fortier M; Bocti C; Fulop T; Paquet N; Cunnane SC
Exp Gerontol; 2018 Jul; 107():18-26. PubMed ID: 28709938
[TBL] [Abstract][Full Text] [Related]
7. Statistical brain mapping of 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains.
Ishii K; Willoch F; Minoshima S; Drzezga A; Ficaro EP; Cross DJ; Kuhl DE; Schwaiger M
J Nucl Med; 2001 Apr; 42(4):548-57. PubMed ID: 11337540
[TBL] [Abstract][Full Text] [Related]
8. Brain FDG PET study of normal aging in Japanese: effect of atrophy correction.
Yanase D; Matsunari I; Yajima K; Chen W; Fujikawa A; Nishimura S; Matsuda H; Yamada M
Eur J Nucl Med Mol Imaging; 2005 Jul; 32(7):794-805. PubMed ID: 15759148
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
Alexander GE; Chen K; Pietrini P; Rapoport SI; Reiman EM
Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126
[TBL] [Abstract][Full Text] [Related]
10. Reduced cerebral glucose metabolism in patients at risk for Alzheimer's disease.
Hunt A; Schönknecht P; Henze M; Seidl U; Haberkorn U; Schröder J
Psychiatry Res; 2007 Jul; 155(2):147-54. PubMed ID: 17524628
[TBL] [Abstract][Full Text] [Related]
11. Selection of the optimal intensity normalization region for FDG-PET studies of normal aging and Alzheimer's disease.
Nugent S; Croteau E; Potvin O; Castellano CA; Dieumegarde L; Cunnane SC; Duchesne S
Sci Rep; 2020 Jun; 10(1):9261. PubMed ID: 32518360
[TBL] [Abstract][Full Text] [Related]
12. Lower brain 18F-fluorodeoxyglucose uptake but normal 11C-acetoacetate metabolism in mild Alzheimer's disease dementia.
Castellano CA; Nugent S; Paquet N; Tremblay S; Bocti C; Lacombe G; Imbeault H; Turcotte É; Fulop T; Cunnane SC
J Alzheimers Dis; 2015; 43(4):1343-53. PubMed ID: 25147107
[TBL] [Abstract][Full Text] [Related]
13. Brain SPET abnormalities in Alzheimer's disease before and after atrophy correction.
Matsuda H; Kanetaka H; Ohnishi T; Asada T; Imabayashi E; Nakano S; Katoh A; Tanaka F
Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1502-5. PubMed ID: 12397471
[TBL] [Abstract][Full Text] [Related]
14. Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity.
Vander Borght T; Minoshima S; Giordani B; Foster NL; Frey KA; Berent S; Albin RL; Koeppe RA; Kuhl DE
J Nucl Med; 1997 May; 38(5):797-802. PubMed ID: 9170449
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid lactate levels and brain [18F]FDG PET hypometabolism within the default mode network in Alzheimer's disease.
Liguori C; Chiaravalloti A; Sancesario G; Stefani A; Sancesario GM; Mercuri NB; Schillaci O; Pierantozzi M
Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):2040-9. PubMed ID: 27221635
[TBL] [Abstract][Full Text] [Related]
16. Resting state brain glucose metabolism is not reduced in normotensive healthy men during aging, after correction for brain atrophy.
Ibáñez V; Pietrini P; Furey ML; Alexander GE; Millet P; Bokde AL; Teichberg D; Schapiro MB; Horwitz B; Rapoport SI
Brain Res Bull; 2004 Mar; 63(2):147-54. PubMed ID: 15130704
[TBL] [Abstract][Full Text] [Related]
17. Direct voxel-based comparison between grey matter hypometabolism and atrophy in Alzheimer's disease.
Chételat G; Desgranges B; Landeau B; Mézenge F; Poline JB; de la Sayette V; Viader F; Eustache F; Baron JC
Brain; 2008 Jan; 131(Pt 1):60-71. PubMed ID: 18063588
[TBL] [Abstract][Full Text] [Related]
18. Partial volume effect-corrected FDG PET and grey matter volume loss in patients with mild Alzheimer's disease.
Samuraki M; Matsunari I; Chen WP; Yajima K; Yanase D; Fujikawa A; Takeda N; Nishimura S; Matsuda H; Yamada M
Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1658-69. PubMed ID: 17520250
[TBL] [Abstract][Full Text] [Related]
19. Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG.
Shin J; Lee SY; Kim SJ; Kim SH; Cho SJ; Kim YB
Neuroimage; 2010 Aug; 52(2):488-96. PubMed ID: 20385246
[TBL] [Abstract][Full Text] [Related]
20. Comparison of positron emission tomography, cognition, and brain volume in Alzheimer's disease with and without severe abnormalities of white matter.
DeCarli C; Grady CL; Clark CM; Katz DA; Brady DR; Murphy DG; Haxby JV; Salerno JA; Gillette JA; Gonzalez-Aviles A; Rapoport SI
J Neurol Neurosurg Psychiatry; 1996 Feb; 60(2):158-67. PubMed ID: 8708645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
